InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.
Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem
Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.
InGeNA the industry voice for the future of genomics in Australia
Planning for Australia’s genomics workforce
Australia has a highly skilled health workforce with diverse educational backgrounds and varying degrees of genomic literacy. We are well placed to build a confident and capable workforce that can integrate genomics into everyday practice and foster a culture of continuous learning. Join our expert speakers as they delve into the various aspects of developing and sustaining our genomics workforce; from defining the knowledge and skills needed, to providing a standardised framework, and ensuring that the future of genomics is ethical and inclusive.
Who we are
InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.
- A patient-centred approach
- Digital infrastructure & principles
- Workforce planning & skills
- Government policy making
VISION Realising the full potential of genomics to personalise healthcare
MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare
Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.
This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative – learn more at mtpconnect.org.au.
“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”
Everyone is welcome to attend the next informative InGeNA webinar to be held on Wednesday 18 August 2021 on the theme of genomics workforce advancement. The event is facilitated by AIDH CEO Dr Louise Schaper with guest speakers Prof Emma Kowal and Amy...
A new report launched last week, long called for by experts in the sector, puts forward a seven-point plan for Government action to improve access to cell and gene therapies. The report called ‘Cell and Gene Therapies: Rising to the Challenge’ – calls for...
The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.
The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.
Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.
A collection of useful references and sources from across Australia’s genomics ecosystem.
- [email protected]
+61 3 9326 3311
Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia